LEVOXINE- levoxine powder
First Priority Incorporated
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
----------
A Palatable Supplement for the Correction of Conditions Associated with Hypothyroidism in Horses and Ponies.
For use in horses and ponies for correction of conditions associated with low circulating thyroid hormone (hypothyrodism).
Doses should be individualized and animals should be monitored daily for clincial signs of hyperthyroidism or hypersensitivity. Suggested initial doses are 1-10 mg levothyroxine sodium (T4)/100 lb body weight (2-20 mg/100 kg) once per day or in divided doses. Response to the administration of Levoxine™ Powder should be evaluated clinically every week until an adequate maintenance dose is established. In most horses, this is usually in the range of 35 to 100 mg total daily dose of T4 (1-3 level tablespoonfuls Levoxine™ Powder).
Each pound (453.6 g) contains:
Levothyroxine Sodium USP ........................................ 0.22% (1.0 g)
One level teaspoonful contains 12 mg of T4: one level tablespoonful contains 36 mg of T4.
WARNING: Administer with caution to animals with clincially significant heart disease, hypertension or other complications for which a sharply increased metabolic rate might prove hazardous. Use in pregnant mares has not been evaluated.
STORAGE: Store at controlled room temperature between 15° - 30°C (59° - 86°F). Keep container tightly closed when not in use.
USE ONLY AS DIRECTED
LEVOXINE
levoxine powder |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - First Priority Incorporated (179925722) |
Registrant - First Priority Incorporated (179925722) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
First Priority Incorporated | 179925722 | manufacture |